Covid-19 Impact on Global Biopharmaceutical Excipients Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-biopharmaceutical-excipients-market-insights-forecast-to-2026_en.gif)
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biopharmaceutical Excipients market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical Excipients industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical Excipients YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical Excipients will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Excipients market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Excipients market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Biopharmaceutical Excipients market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Biopharmaceutical Excipients market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical Excipients market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical Excipients market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Excipients market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Excipients market.
The following manufacturers are covered in this report:
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical Excipients industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical Excipients YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical Excipients will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Excipients market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Excipients market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Biopharmaceutical Excipients market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Biopharmaceutical Excipients market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical Excipients market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical Excipients market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Excipients market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Excipients market.
The following manufacturers are covered in this report:
- BASF SE
- ABITEC Corp
- Colorcon, Inc
- DFE Pharma
- Meggle AG
- Pharmonix Biological
- Roquette
- Sigachi Industries
- Signet Chemical Corporation
- Spectrum Chemical Manufacturing Corp
- SPI Pharma
- Solubilizers& Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Other
- Biopharmaceutical Downstream
- Biopharmaceutical Upstream
1 STUDY COVERAGE
1.1 Biopharmaceutical Excipients Product Introduction
1.2 Market Segments
1.3 Key Biopharmaceutical Excipients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Type
1.4.2 Solubilizers& Surfactants/Emulsifiers
1.4.3 Polyols
1.4.4 Carbohydrates
1.4.5 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Downstream
1.5.3 Biopharmaceutical Upstream
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Excipients Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Excipients Industry
1.6.1.1 Biopharmaceutical Excipients Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical Excipients Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical Excipients Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biopharmaceutical Excipients Market Size Estimates and Forecasts
2.1.1 Global Biopharmaceutical Excipients Revenue 2015-2026
2.1.2 Global Biopharmaceutical Excipients Sales 2015-2026
2.2 Biopharmaceutical Excipients Market Size by Region: 2020 Versus 2026
2.2.1 Global Biopharmaceutical Excipients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biopharmaceutical Excipients Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOPHARMACEUTICAL EXCIPIENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biopharmaceutical Excipients Sales by Manufacturers
3.1.1 Biopharmaceutical Excipients Sales by Manufacturers (2015-2020)
3.1.2 Biopharmaceutical Excipients Sales Market Share by Manufacturers (2015-2020)
3.2 Biopharmaceutical Excipients Revenue by Manufacturers
3.2.1 Biopharmaceutical Excipients Revenue by Manufacturers (2015-2020)
3.2.2 Biopharmaceutical Excipients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biopharmaceutical Excipients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biopharmaceutical Excipients Revenue in 2019
3.2.5 Global Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biopharmaceutical Excipients Price by Manufacturers
3.4 Biopharmaceutical Excipients Manufacturing Base Distribution, Product Types
3.4.1 Biopharmaceutical Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopharmaceutical Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biopharmaceutical Excipients Market Size by Type (2015-2020)
4.1.1 Global Biopharmaceutical Excipients Sales by Type (2015-2020)
4.1.2 Global Biopharmaceutical Excipients Revenue by Type (2015-2020)
4.1.3 Biopharmaceutical Excipients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biopharmaceutical Excipients Market Size Forecast by Type (2021-2026)
4.2.1 Global Biopharmaceutical Excipients Sales Forecast by Type (2021-2026)
4.2.2 Global Biopharmaceutical Excipients Revenue Forecast by Type (2021-2026)
4.2.3 Biopharmaceutical Excipients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biopharmaceutical Excipients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biopharmaceutical Excipients Market Size by Application (2015-2020)
5.1.1 Global Biopharmaceutical Excipients Sales by Application (2015-2020)
5.1.2 Global Biopharmaceutical Excipients Revenue by Application (2015-2020)
5.1.3 Biopharmaceutical Excipients Price by Application (2015-2020)
5.2 Biopharmaceutical Excipients Market Size Forecast by Application (2021-2026)
5.2.1 Global Biopharmaceutical Excipients Sales Forecast by Application (2021-2026)
5.2.2 Global Biopharmaceutical Excipients Revenue Forecast by Application (2021-2026)
5.2.3 Global Biopharmaceutical Excipients Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biopharmaceutical Excipients by Country
6.1.1 North America Biopharmaceutical Excipients Sales by Country
6.1.2 North America Biopharmaceutical Excipients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biopharmaceutical Excipients Market Facts & Figures by Type
6.3 North America Biopharmaceutical Excipients Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biopharmaceutical Excipients Market Facts & Figures by Type
7.3 Europe Biopharmaceutical Excipients Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biopharmaceutical Excipients by Region
8.1.1 Asia Pacific Biopharmaceutical Excipients Sales by Region
8.1.2 Asia Pacific Biopharmaceutical Excipients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Type
8.3 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biopharmaceutical Excipients by Country
9.1.1 Latin America Biopharmaceutical Excipients Sales by Country
9.1.2 Latin America Biopharmaceutical Excipients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biopharmaceutical Excipients Market Facts & Figures by Type
9.3 Central & South America Biopharmaceutical Excipients Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biopharmaceutical Excipients by Country
10.1.1 Middle East and Africa Biopharmaceutical Excipients Sales by Country
10.1.2 Middle East and Africa Biopharmaceutical Excipients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Type
10.3 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 BASF SE
11.1.1 BASF SE Corporation Information
11.1.2 BASF SE Description, Business Overview and Total Revenue
11.1.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF SE Biopharmaceutical Excipients Products Offered
11.1.5 BASF SE Recent Development
11.2 ABITEC Corp
11.2.1 ABITEC Corp Corporation Information
11.2.2 ABITEC Corp Description, Business Overview and Total Revenue
11.2.3 ABITEC Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ABITEC Corp Biopharmaceutical Excipients Products Offered
11.2.5 ABITEC Corp Recent Development
11.3 Colorcon, Inc
11.3.1 Colorcon, Inc Corporation Information
11.3.2 Colorcon, Inc Description, Business Overview and Total Revenue
11.3.3 Colorcon, Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Colorcon, Inc Biopharmaceutical Excipients Products Offered
11.3.5 Colorcon, Inc Recent Development
11.4 DFE Pharma
11.4.1 DFE Pharma Corporation Information
11.4.2 DFE Pharma Description, Business Overview and Total Revenue
11.4.3 DFE Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 DFE Pharma Biopharmaceutical Excipients Products Offered
11.4.5 DFE Pharma Recent Development
11.5 Meggle AG
11.5.1 Meggle AG Corporation Information
11.5.2 Meggle AG Description, Business Overview and Total Revenue
11.5.3 Meggle AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Meggle AG Biopharmaceutical Excipients Products Offered
11.5.5 Meggle AG Recent Development
11.6 Pharmonix Biological
11.6.1 Pharmonix Biological Corporation Information
11.6.2 Pharmonix Biological Description, Business Overview and Total Revenue
11.6.3 Pharmonix Biological Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pharmonix Biological Biopharmaceutical Excipients Products Offered
11.6.5 Pharmonix Biological Recent Development
11.7 Roquette
11.7.1 Roquette Corporation Information
11.7.2 Roquette Description, Business Overview and Total Revenue
11.7.3 Roquette Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roquette Biopharmaceutical Excipients Products Offered
11.7.5 Roquette Recent Development
11.8 Sigachi Industries
11.8.1 Sigachi Industries Corporation Information
11.8.2 Sigachi Industries Description, Business Overview and Total Revenue
11.8.3 Sigachi Industries Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sigachi Industries Biopharmaceutical Excipients Products Offered
11.8.5 Sigachi Industries Recent Development
11.9 Signet Chemical Corporation
11.9.1 Signet Chemical Corporation Corporation Information
11.9.2 Signet Chemical Corporation Description, Business Overview and Total Revenue
11.9.3 Signet Chemical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Products Offered
11.9.5 Signet Chemical Corporation Recent Development
11.10 Spectrum Chemical Manufacturing Corp
11.10.1 Spectrum Chemical Manufacturing Corp Corporation Information
11.10.2 Spectrum Chemical Manufacturing Corp Description, Business Overview and Total Revenue
11.10.3 Spectrum Chemical Manufacturing Corp Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Products Offered
11.10.5 Spectrum Chemical Manufacturing Corp Recent Development
11.1 BASF SE
11.1.1 BASF SE Corporation Information
11.1.2 BASF SE Description, Business Overview and Total Revenue
11.1.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF SE Biopharmaceutical Excipients Products Offered
11.1.5 BASF SE Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biopharmaceutical Excipients Market Estimates and Projections by Region
12.1.1 Global Biopharmaceutical Excipients Sales Forecast by Regions 2021-2026
12.1.2 Global Biopharmaceutical Excipients Revenue Forecast by Regions 2021-2026
12.2 North America Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.2.1 North America: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.2.2 North America: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.2.3 North America: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.3 Europe Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.3.1 Europe: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.3.2 Europe: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.3.3 Europe: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biopharmaceutical Excipients Market Size Forecast by Region (2021-2026)
12.5 Latin America Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.5.1 Latin America: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.5.2 Latin America: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.5.3 Latin America: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biopharmaceutical Excipients Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biopharmaceutical Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Biopharmaceutical Excipients Product Introduction
1.2 Market Segments
1.3 Key Biopharmaceutical Excipients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Type
1.4.2 Solubilizers& Surfactants/Emulsifiers
1.4.3 Polyols
1.4.4 Carbohydrates
1.4.5 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Downstream
1.5.3 Biopharmaceutical Upstream
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Excipients Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Excipients Industry
1.6.1.1 Biopharmaceutical Excipients Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical Excipients Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical Excipients Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biopharmaceutical Excipients Market Size Estimates and Forecasts
2.1.1 Global Biopharmaceutical Excipients Revenue 2015-2026
2.1.2 Global Biopharmaceutical Excipients Sales 2015-2026
2.2 Biopharmaceutical Excipients Market Size by Region: 2020 Versus 2026
2.2.1 Global Biopharmaceutical Excipients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biopharmaceutical Excipients Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOPHARMACEUTICAL EXCIPIENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biopharmaceutical Excipients Sales by Manufacturers
3.1.1 Biopharmaceutical Excipients Sales by Manufacturers (2015-2020)
3.1.2 Biopharmaceutical Excipients Sales Market Share by Manufacturers (2015-2020)
3.2 Biopharmaceutical Excipients Revenue by Manufacturers
3.2.1 Biopharmaceutical Excipients Revenue by Manufacturers (2015-2020)
3.2.2 Biopharmaceutical Excipients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biopharmaceutical Excipients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biopharmaceutical Excipients Revenue in 2019
3.2.5 Global Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biopharmaceutical Excipients Price by Manufacturers
3.4 Biopharmaceutical Excipients Manufacturing Base Distribution, Product Types
3.4.1 Biopharmaceutical Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopharmaceutical Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biopharmaceutical Excipients Market Size by Type (2015-2020)
4.1.1 Global Biopharmaceutical Excipients Sales by Type (2015-2020)
4.1.2 Global Biopharmaceutical Excipients Revenue by Type (2015-2020)
4.1.3 Biopharmaceutical Excipients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biopharmaceutical Excipients Market Size Forecast by Type (2021-2026)
4.2.1 Global Biopharmaceutical Excipients Sales Forecast by Type (2021-2026)
4.2.2 Global Biopharmaceutical Excipients Revenue Forecast by Type (2021-2026)
4.2.3 Biopharmaceutical Excipients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biopharmaceutical Excipients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biopharmaceutical Excipients Market Size by Application (2015-2020)
5.1.1 Global Biopharmaceutical Excipients Sales by Application (2015-2020)
5.1.2 Global Biopharmaceutical Excipients Revenue by Application (2015-2020)
5.1.3 Biopharmaceutical Excipients Price by Application (2015-2020)
5.2 Biopharmaceutical Excipients Market Size Forecast by Application (2021-2026)
5.2.1 Global Biopharmaceutical Excipients Sales Forecast by Application (2021-2026)
5.2.2 Global Biopharmaceutical Excipients Revenue Forecast by Application (2021-2026)
5.2.3 Global Biopharmaceutical Excipients Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biopharmaceutical Excipients by Country
6.1.1 North America Biopharmaceutical Excipients Sales by Country
6.1.2 North America Biopharmaceutical Excipients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biopharmaceutical Excipients Market Facts & Figures by Type
6.3 North America Biopharmaceutical Excipients Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biopharmaceutical Excipients Market Facts & Figures by Type
7.3 Europe Biopharmaceutical Excipients Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biopharmaceutical Excipients by Region
8.1.1 Asia Pacific Biopharmaceutical Excipients Sales by Region
8.1.2 Asia Pacific Biopharmaceutical Excipients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Type
8.3 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biopharmaceutical Excipients by Country
9.1.1 Latin America Biopharmaceutical Excipients Sales by Country
9.1.2 Latin America Biopharmaceutical Excipients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biopharmaceutical Excipients Market Facts & Figures by Type
9.3 Central & South America Biopharmaceutical Excipients Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biopharmaceutical Excipients by Country
10.1.1 Middle East and Africa Biopharmaceutical Excipients Sales by Country
10.1.2 Middle East and Africa Biopharmaceutical Excipients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Type
10.3 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 BASF SE
11.1.1 BASF SE Corporation Information
11.1.2 BASF SE Description, Business Overview and Total Revenue
11.1.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF SE Biopharmaceutical Excipients Products Offered
11.1.5 BASF SE Recent Development
11.2 ABITEC Corp
11.2.1 ABITEC Corp Corporation Information
11.2.2 ABITEC Corp Description, Business Overview and Total Revenue
11.2.3 ABITEC Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ABITEC Corp Biopharmaceutical Excipients Products Offered
11.2.5 ABITEC Corp Recent Development
11.3 Colorcon, Inc
11.3.1 Colorcon, Inc Corporation Information
11.3.2 Colorcon, Inc Description, Business Overview and Total Revenue
11.3.3 Colorcon, Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Colorcon, Inc Biopharmaceutical Excipients Products Offered
11.3.5 Colorcon, Inc Recent Development
11.4 DFE Pharma
11.4.1 DFE Pharma Corporation Information
11.4.2 DFE Pharma Description, Business Overview and Total Revenue
11.4.3 DFE Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 DFE Pharma Biopharmaceutical Excipients Products Offered
11.4.5 DFE Pharma Recent Development
11.5 Meggle AG
11.5.1 Meggle AG Corporation Information
11.5.2 Meggle AG Description, Business Overview and Total Revenue
11.5.3 Meggle AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Meggle AG Biopharmaceutical Excipients Products Offered
11.5.5 Meggle AG Recent Development
11.6 Pharmonix Biological
11.6.1 Pharmonix Biological Corporation Information
11.6.2 Pharmonix Biological Description, Business Overview and Total Revenue
11.6.3 Pharmonix Biological Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pharmonix Biological Biopharmaceutical Excipients Products Offered
11.6.5 Pharmonix Biological Recent Development
11.7 Roquette
11.7.1 Roquette Corporation Information
11.7.2 Roquette Description, Business Overview and Total Revenue
11.7.3 Roquette Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roquette Biopharmaceutical Excipients Products Offered
11.7.5 Roquette Recent Development
11.8 Sigachi Industries
11.8.1 Sigachi Industries Corporation Information
11.8.2 Sigachi Industries Description, Business Overview and Total Revenue
11.8.3 Sigachi Industries Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sigachi Industries Biopharmaceutical Excipients Products Offered
11.8.5 Sigachi Industries Recent Development
11.9 Signet Chemical Corporation
11.9.1 Signet Chemical Corporation Corporation Information
11.9.2 Signet Chemical Corporation Description, Business Overview and Total Revenue
11.9.3 Signet Chemical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Products Offered
11.9.5 Signet Chemical Corporation Recent Development
11.10 Spectrum Chemical Manufacturing Corp
11.10.1 Spectrum Chemical Manufacturing Corp Corporation Information
11.10.2 Spectrum Chemical Manufacturing Corp Description, Business Overview and Total Revenue
11.10.3 Spectrum Chemical Manufacturing Corp Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Products Offered
11.10.5 Spectrum Chemical Manufacturing Corp Recent Development
11.1 BASF SE
11.1.1 BASF SE Corporation Information
11.1.2 BASF SE Description, Business Overview and Total Revenue
11.1.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BASF SE Biopharmaceutical Excipients Products Offered
11.1.5 BASF SE Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biopharmaceutical Excipients Market Estimates and Projections by Region
12.1.1 Global Biopharmaceutical Excipients Sales Forecast by Regions 2021-2026
12.1.2 Global Biopharmaceutical Excipients Revenue Forecast by Regions 2021-2026
12.2 North America Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.2.1 North America: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.2.2 North America: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.2.3 North America: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.3 Europe Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.3.1 Europe: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.3.2 Europe: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.3.3 Europe: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biopharmaceutical Excipients Market Size Forecast by Region (2021-2026)
12.5 Latin America Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.5.1 Latin America: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.5.2 Latin America: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.5.3 Latin America: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biopharmaceutical Excipients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biopharmaceutical Excipients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biopharmaceutical Excipients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biopharmaceutical Excipients Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biopharmaceutical Excipients Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biopharmaceutical Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Biopharmaceutical Excipients Market Segments
Table 2. Ranking of Global Top Biopharmaceutical Excipients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Excipients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Solubilizers& Surfactants/Emulsifiers
Table 5. Major Manufacturers of Polyols
Table 6. Major Manufacturers of Carbohydrates
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Biopharmaceutical Excipients Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Biopharmaceutical Excipients Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Biopharmaceutical Excipients Players to Combat Covid-19 Impact
Table 13. Global Biopharmaceutical Excipients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Biopharmaceutical Excipients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Biopharmaceutical Excipients Sales by Regions 2015-2020 (K MT)
Table 16. Global Biopharmaceutical Excipients Sales Market Share by Regions (2015-2020)
Table 17. Global Biopharmaceutical Excipients Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Biopharmaceutical Excipients Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Biopharmaceutical Excipients Sales Share by Manufacturers (2015-2020)
Table 20. Global Biopharmaceutical Excipients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Biopharmaceutical Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Excipients as of 2019)
Table 22. Biopharmaceutical Excipients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Biopharmaceutical Excipients Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Biopharmaceutical Excipients Price (2015-2020) (USD/MT)
Table 25. Biopharmaceutical Excipients Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Biopharmaceutical Excipients Product Type
Table 27. Date of International Manufacturers Enter into Biopharmaceutical Excipients Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 30. Global Biopharmaceutical Excipients Sales Share by Type (2015-2020)
Table 31. Global Biopharmaceutical Excipients Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Biopharmaceutical Excipients Revenue Share by Type (2015-2020)
Table 33. Biopharmaceutical Excipients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 35. Global Biopharmaceutical Excipients Sales Share by Application (2015-2020)
Table 36. North America Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 37. North America Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 38. North America Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 40. North America Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 41. North America Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 42. North America Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 43. North America Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 44. Europe Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 45. Europe Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 46. Europe Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 48. Europe Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 49. Europe Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 50. Europe Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 51. Europe Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Biopharmaceutical Excipients Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Biopharmaceutical Excipients Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Biopharmaceutical Excipients Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 60. Latin America Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 61. Latin America Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 64. Latin America Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 65. Latin America Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 66. Latin America Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 67. Latin America Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 76. BASF SE Corporation Information
Table 77. BASF SE Description and Major Businesses
Table 78. BASF SE Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. BASF SE Product
Table 80. BASF SE Recent Development
Table 81. ABITEC Corp Corporation Information
Table 82. ABITEC Corp Description and Major Businesses
Table 83. ABITEC Corp Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. ABITEC Corp Product
Table 85. ABITEC Corp Recent Development
Table 86. Colorcon, Inc Corporation Information
Table 87. Colorcon, Inc Description and Major Businesses
Table 88. Colorcon, Inc Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Colorcon, Inc Product
Table 90. Colorcon, Inc Recent Development
Table 91. DFE Pharma Corporation Information
Table 92. DFE Pharma Description and Major Businesses
Table 93. DFE Pharma Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. DFE Pharma Product
Table 95. DFE Pharma Recent Development
Table 96. Meggle AG Corporation Information
Table 97. Meggle AG Description and Major Businesses
Table 98. Meggle AG Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Meggle AG Product
Table 100. Meggle AG Recent Development
Table 101. Pharmonix Biological Corporation Information
Table 102. Pharmonix Biological Description and Major Businesses
Table 103. Pharmonix Biological Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Pharmonix Biological Product
Table 105. Pharmonix Biological Recent Development
Table 106. Roquette Corporation Information
Table 107. Roquette Description and Major Businesses
Table 108. Roquette Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Roquette Product
Table 110. Roquette Recent Development
Table 111. Sigachi Industries Corporation Information
Table 112. Sigachi Industries Description and Major Businesses
Table 113. Sigachi Industries Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Sigachi Industries Product
Table 115. Sigachi Industries Recent Development
Table 116. Signet Chemical Corporation Corporation Information
Table 117. Signet Chemical Corporation Description and Major Businesses
Table 118. Signet Chemical Corporation Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Signet Chemical Corporation Product
Table 120. Signet Chemical Corporation Recent Development
Table 121. Spectrum Chemical Manufacturing Corp Corporation Information
Table 122. Spectrum Chemical Manufacturing Corp Description and Major Businesses
Table 123. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Spectrum Chemical Manufacturing Corp Product
Table 125. Spectrum Chemical Manufacturing Corp Recent Development
Table 126. SPI Pharma Corporation Information
Table 127. SPI Pharma Description and Major Businesses
Table 128. SPI Pharma Biopharmaceutical Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. SPI Pharma Product
Table 130. SPI Pharma Recent Development
Table 131. Global Biopharmaceutical Excipients Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Biopharmaceutical Excipients Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Biopharmaceutical Excipients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Biopharmaceutical Excipients Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Biopharmaceutical Excipients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Biopharmaceutical Excipients Players
Table 149. Biopharmaceutical Excipients Customers List
Table 150. Biopharmaceutical Excipients Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Biopharmaceutical Excipients Market Segments
Table 2. Ranking of Global Top Biopharmaceutical Excipients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Excipients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Solubilizers& Surfactants/Emulsifiers
Table 5. Major Manufacturers of Polyols
Table 6. Major Manufacturers of Carbohydrates
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Biopharmaceutical Excipients Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Biopharmaceutical Excipients Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Biopharmaceutical Excipients Players to Combat Covid-19 Impact
Table 13. Global Biopharmaceutical Excipients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Biopharmaceutical Excipients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Biopharmaceutical Excipients Sales by Regions 2015-2020 (K MT)
Table 16. Global Biopharmaceutical Excipients Sales Market Share by Regions (2015-2020)
Table 17. Global Biopharmaceutical Excipients Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Biopharmaceutical Excipients Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Biopharmaceutical Excipients Sales Share by Manufacturers (2015-2020)
Table 20. Global Biopharmaceutical Excipients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Biopharmaceutical Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Excipients as of 2019)
Table 22. Biopharmaceutical Excipients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Biopharmaceutical Excipients Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Biopharmaceutical Excipients Price (2015-2020) (USD/MT)
Table 25. Biopharmaceutical Excipients Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Biopharmaceutical Excipients Product Type
Table 27. Date of International Manufacturers Enter into Biopharmaceutical Excipients Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 30. Global Biopharmaceutical Excipients Sales Share by Type (2015-2020)
Table 31. Global Biopharmaceutical Excipients Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Biopharmaceutical Excipients Revenue Share by Type (2015-2020)
Table 33. Biopharmaceutical Excipients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 35. Global Biopharmaceutical Excipients Sales Share by Application (2015-2020)
Table 36. North America Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 37. North America Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 38. North America Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 40. North America Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 41. North America Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 42. North America Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 43. North America Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 44. Europe Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 45. Europe Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 46. Europe Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 48. Europe Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 49. Europe Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 50. Europe Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 51. Europe Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Biopharmaceutical Excipients Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Biopharmaceutical Excipients Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Biopharmaceutical Excipients Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 60. Latin America Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 61. Latin America Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 64. Latin America Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 65. Latin America Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 66. Latin America Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 67. Latin America Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Biopharmaceutical Excipients Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Biopharmaceutical Excipients Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Biopharmaceutical Excipients Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Biopharmaceutical Excipients Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Biopharmaceutical Excipients Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Table 76. BASF SE Corporation Information
Table 77. BASF SE Description and Major Businesses
Table 78. BASF SE Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. BASF SE Product
Table 80. BASF SE Recent Development
Table 81. ABITEC Corp Corporation Information
Table 82. ABITEC Corp Description and Major Businesses
Table 83. ABITEC Corp Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. ABITEC Corp Product
Table 85. ABITEC Corp Recent Development
Table 86. Colorcon, Inc Corporation Information
Table 87. Colorcon, Inc Description and Major Businesses
Table 88. Colorcon, Inc Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Colorcon, Inc Product
Table 90. Colorcon, Inc Recent Development
Table 91. DFE Pharma Corporation Information
Table 92. DFE Pharma Description and Major Businesses
Table 93. DFE Pharma Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. DFE Pharma Product
Table 95. DFE Pharma Recent Development
Table 96. Meggle AG Corporation Information
Table 97. Meggle AG Description and Major Businesses
Table 98. Meggle AG Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Meggle AG Product
Table 100. Meggle AG Recent Development
Table 101. Pharmonix Biological Corporation Information
Table 102. Pharmonix Biological Description and Major Businesses
Table 103. Pharmonix Biological Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Pharmonix Biological Product
Table 105. Pharmonix Biological Recent Development
Table 106. Roquette Corporation Information
Table 107. Roquette Description and Major Businesses
Table 108. Roquette Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Roquette Product
Table 110. Roquette Recent Development
Table 111. Sigachi Industries Corporation Information
Table 112. Sigachi Industries Description and Major Businesses
Table 113. Sigachi Industries Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Sigachi Industries Product
Table 115. Sigachi Industries Recent Development
Table 116. Signet Chemical Corporation Corporation Information
Table 117. Signet Chemical Corporation Description and Major Businesses
Table 118. Signet Chemical Corporation Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Signet Chemical Corporation Product
Table 120. Signet Chemical Corporation Recent Development
Table 121. Spectrum Chemical Manufacturing Corp Corporation Information
Table 122. Spectrum Chemical Manufacturing Corp Description and Major Businesses
Table 123. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Spectrum Chemical Manufacturing Corp Product
Table 125. Spectrum Chemical Manufacturing Corp Recent Development
Table 126. SPI Pharma Corporation Information
Table 127. SPI Pharma Description and Major Businesses
Table 128. SPI Pharma Biopharmaceutical Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. SPI Pharma Product
Table 130. SPI Pharma Recent Development
Table 131. Global Biopharmaceutical Excipients Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Biopharmaceutical Excipients Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Biopharmaceutical Excipients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Biopharmaceutical Excipients Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Biopharmaceutical Excipients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Biopharmaceutical Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Biopharmaceutical Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Biopharmaceutical Excipients Players
Table 149. Biopharmaceutical Excipients Customers List
Table 150. Biopharmaceutical Excipients Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Biopharmaceutical Excipients Product Picture
Figure 2. Global Biopharmaceutical Excipients Sales Market Share by Type in 2020 & 2026
Figure 3. Solubilizers& Surfactants/Emulsifiers Product Picture
Figure 4. Polyols Product Picture
Figure 5. Carbohydrates Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biopharmaceutical Excipients Sales Market Share by Application in 2020 & 2026
Figure 8. Biopharmaceutical Downstream
Figure 9. Biopharmaceutical Upstream
Figure 10. Biopharmaceutical Excipients Report Years Considered
Figure 11. Global Biopharmaceutical Excipients Market Size 2015-2026 (US$ Million)
Figure 12. Global Biopharmaceutical Excipients Sales 2015-2026 (K MT)
Figure 13. Global Biopharmaceutical Excipients Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Biopharmaceutical Excipients Sales Market Share by Region (2015-2020)
Figure 15. Global Biopharmaceutical Excipients Sales Market Share by Region in 2019
Figure 16. Global Biopharmaceutical Excipients Revenue Market Share by Region (2015-2020)
Figure 17. Global Biopharmaceutical Excipients Revenue Market Share by Region in 2019
Figure 18. Global Biopharmaceutical Excipients Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Biopharmaceutical Excipients Revenue in 2019
Figure 20. Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Figure 22. Global Biopharmaceutical Excipients Sales Market Share by Type in 2019
Figure 23. Global Biopharmaceutical Excipients Revenue Market Share by Type (2015-2020)
Figure 24. Global Biopharmaceutical Excipients Revenue Market Share by Type in 2019
Figure 25. Global Biopharmaceutical Excipients Market Share by Price Range (2015-2020)
Figure 26. Global Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Figure 27. Global Biopharmaceutical Excipients Sales Market Share by Application in 2019
Figure 28. Global Biopharmaceutical Excipients Revenue Market Share by Application (2015-2020)
Figure 29. Global Biopharmaceutical Excipients Revenue Market Share by Application in 2019
Figure 30. North America Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 33. North America Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 34. U.S. Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Biopharmaceutical Excipients Market Share by Type in 2019
Figure 39. North America Biopharmaceutical Excipients Market Share by Application in 2019
Figure 40. Europe Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 43. Europe Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 44. Germany Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Biopharmaceutical Excipients Market Share by Type in 2019
Figure 55. Europe Biopharmaceutical Excipients Market Share by Application in 2019
Figure 56. Asia Pacific Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Region in 2019
Figure 59. Asia Pacific Biopharmaceutical Excipients Revenue Market Share by Region in 2019
Figure 60. China Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Biopharmaceutical Excipients Market Share by Type in 2019
Figure 83. Asia Pacific Biopharmaceutical Excipients Market Share by Application in 2019
Figure 84. Latin America Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 87. Latin America Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 88. Mexico Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Biopharmaceutical Excipients Market Share by Type in 2019
Figure 95. Latin America Biopharmaceutical Excipients Market Share by Application in 2019
Figure 96. Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 100. Turkey Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Biopharmaceutical Excipients Market Share by Type in 2019
Figure 107. Middle East and Africa Biopharmaceutical Excipients Market Share by Application in 2019
Figure 108. BASF SE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. ABITEC Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Colorcon, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. DFE Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Meggle AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pharmonix Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Roquette Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sigachi Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Signet Chemical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Spectrum Chemical Manufacturing Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. SPI Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. North America Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Europe Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Asia Pacific Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Latin America Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Middle East and Africa Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Biopharmaceutical Excipients Product Picture
Figure 2. Global Biopharmaceutical Excipients Sales Market Share by Type in 2020 & 2026
Figure 3. Solubilizers& Surfactants/Emulsifiers Product Picture
Figure 4. Polyols Product Picture
Figure 5. Carbohydrates Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biopharmaceutical Excipients Sales Market Share by Application in 2020 & 2026
Figure 8. Biopharmaceutical Downstream
Figure 9. Biopharmaceutical Upstream
Figure 10. Biopharmaceutical Excipients Report Years Considered
Figure 11. Global Biopharmaceutical Excipients Market Size 2015-2026 (US$ Million)
Figure 12. Global Biopharmaceutical Excipients Sales 2015-2026 (K MT)
Figure 13. Global Biopharmaceutical Excipients Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Biopharmaceutical Excipients Sales Market Share by Region (2015-2020)
Figure 15. Global Biopharmaceutical Excipients Sales Market Share by Region in 2019
Figure 16. Global Biopharmaceutical Excipients Revenue Market Share by Region (2015-2020)
Figure 17. Global Biopharmaceutical Excipients Revenue Market Share by Region in 2019
Figure 18. Global Biopharmaceutical Excipients Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Biopharmaceutical Excipients Revenue in 2019
Figure 20. Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Biopharmaceutical Excipients Sales Market Share by Type (2015-2020)
Figure 22. Global Biopharmaceutical Excipients Sales Market Share by Type in 2019
Figure 23. Global Biopharmaceutical Excipients Revenue Market Share by Type (2015-2020)
Figure 24. Global Biopharmaceutical Excipients Revenue Market Share by Type in 2019
Figure 25. Global Biopharmaceutical Excipients Market Share by Price Range (2015-2020)
Figure 26. Global Biopharmaceutical Excipients Sales Market Share by Application (2015-2020)
Figure 27. Global Biopharmaceutical Excipients Sales Market Share by Application in 2019
Figure 28. Global Biopharmaceutical Excipients Revenue Market Share by Application (2015-2020)
Figure 29. Global Biopharmaceutical Excipients Revenue Market Share by Application in 2019
Figure 30. North America Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 33. North America Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 34. U.S. Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Biopharmaceutical Excipients Market Share by Type in 2019
Figure 39. North America Biopharmaceutical Excipients Market Share by Application in 2019
Figure 40. Europe Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 43. Europe Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 44. Germany Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Biopharmaceutical Excipients Market Share by Type in 2019
Figure 55. Europe Biopharmaceutical Excipients Market Share by Application in 2019
Figure 56. Asia Pacific Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Biopharmaceutical Excipients Sales Market Share by Region in 2019
Figure 59. Asia Pacific Biopharmaceutical Excipients Revenue Market Share by Region in 2019
Figure 60. China Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Biopharmaceutical Excipients Market Share by Type in 2019
Figure 83. Asia Pacific Biopharmaceutical Excipients Market Share by Application in 2019
Figure 84. Latin America Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 87. Latin America Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 88. Mexico Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Biopharmaceutical Excipients Market Share by Type in 2019
Figure 95. Latin America Biopharmaceutical Excipients Market Share by Application in 2019
Figure 96. Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Biopharmaceutical Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Biopharmaceutical Excipients Revenue Market Share by Country in 2019
Figure 100. Turkey Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Biopharmaceutical Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Biopharmaceutical Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Biopharmaceutical Excipients Market Share by Type in 2019
Figure 107. Middle East and Africa Biopharmaceutical Excipients Market Share by Application in 2019
Figure 108. BASF SE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. ABITEC Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Colorcon, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. DFE Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Meggle AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pharmonix Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Roquette Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sigachi Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Signet Chemical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Spectrum Chemical Manufacturing Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. SPI Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. North America Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Europe Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Asia Pacific Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Latin America Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Middle East and Africa Biopharmaceutical Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed